China Biologic Products Inc  

(Public, NASDAQ:CBPO)   Watch this stock  
Find more results for CBPO
+3.90 (3.31%)
After Hours: 121.60 0.00 (0.00%)
Jul 28, 4:33PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 116.27 - 123.88
52 week 80.60 - 144.29
Open 118.08
Vol / Avg. 248,529.00/203,427.00
Mkt cap 3.20B
P/E 36.67
Div/yield     -
EPS 3.32
Shares 26.80M
Beta 1.74
Inst. own 69%
Aug 5, 2016
Q2 2016 China Biologic Products Inc Earnings Call - 7:30AM EDT - Add to calendar
Aug 4, 2016
Q2 2016 China Biologic Products Inc Earnings Release - 4:00PM EDT - Add to calendar
May 5, 2016
Q1 2016 China Biologic Products Inc Earnings Call
May 4, 2016
Q1 2016 China Biologic Products Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 38.25% 38.49%
Operating margin 44.27% 44.72%
EBITD margin - 47.77%
Return on average assets 23.37% 22.86%
Return on average equity 26.35% 29.26%
Employees 1,726 -
CDP Score - -


Room1801, Jialong Intrntnl Bldg 19 Chaoyang Park Road Chaoyang District
+86-10-65983099 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


China Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates in the manufacture and sales of human plasma products segment. It has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across over nine categories. Its principal products are human albumin and immunoglobulin for intravenous injection (IVIG). China Biologic operates its business through approximately two subsidiaries, namely, Shandong Taibang Biological Products Co. Ltd. and Guizhou Taibang Biological Products Co., Ltd. The Company also holds an interest in Xi'an Huitian Blood Products Co., Ltd., a plasma products company. Its products also include Human rabies immunoglobulin, Human tetanus immunoglobulin, Placenta polypeptide, Factor VIII and Human prothrombin complex concentrate.

Officers and directors

Xiaoying Gao Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
Ming Yang CPA Chief Financial Officer, Director
Age: 43
Bio & Compensation  - Reuters
Zhijing Liu Corporate Vice President
Age: 61
Bio & Compensation  - Reuters
Ming Yin Senior Corporate Vice President
Age: 37
Bio & Compensation  - Reuters
Gang Yang Corporate Vice President, General Manager of Guizhou Taibang
Age: 50
Bio & Compensation  - Reuters
Min Fang Director
Age: 35
Bio & Compensation  - Reuters
David Hui Li Director
Age: 46
Bio & Compensation  - Reuters
Joseph J. Chow Independent Director
Age: 53
Bio & Compensation  - Reuters
Wenfang Liu Independent Director
Age: 78
Bio & Compensation  - Reuters
Yungang Lu Independent Director
Age: 51
Bio & Compensation  - Reuters